RT Journal Article
SR Electronic
T1 A framework for quantifying the coupling between brain connectivity and heartbeat dynamics: Insights into the disrupted network physiology in Parkinson’s disease
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.07.20.23292942
DO 10.1101/2023.07.20.23292942
A1 Candia-Rivera, Diego
A1 Vidailhet, Marie
A1 Chavez, Mario
A1 de Vico Fallani, Fabrizio
YR 2024
UL http://medrxiv.org/content/early/2024/03/11/2023.07.20.23292942.abstract
AB Parkinson’s disease (PD) often shows disrupted brain connectivity and autonomic dysfunctions, progressing alongside with motor and cognitive decline. Recently, PD has been linked to a reduced sensitivity to cardiac inputs, i.e., cardiac interoception. Altogether, those signs suggest that PD causes an altered brain-heart connection whose mechanisms remain unclear. Our study aimed to explore the large-scale network disruptions and the neurophysiology of disrupted interoceptive mechanisms in PD. We focused on examining the alterations in brain-heart coupling in PD and their potential connection to motor symptoms. We developed a proof-of-concept method to quantify relationships between the co-fluctuations of brain connectivity and cardiac sympathetic and parasympathetic activities. We quantified the brain-heart couplings from EEG and ECG recordings from PD patients on and off dopaminergic medication, as well as in healthy individuals at rest. Our results show that the couplings of fluctuating alpha and gamma connectivity with cardiac sympathetic dynamics are reduced in PD patients, as compared to healthy individuals. Furthermore, we show that PD patients under dopamine medication recover part of the brain-heart coupling, in proportion with the reduced motor symptoms. Our proposal offers a promising approach to unveil the physiopathology of PD and promoting the development of new evaluation methods for the early stages of the disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch supported by Agence Nationale de la Recherche (France), grant ANR-20-CE37-0012-03.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The data is part of a publicly available dataset UC San Diego Resting State EEG Data from Patients with Parkinson's Disease, gathered from OpenNeuro.org the 21st of November of 2022I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data is part of a publicly available dataset UC San Diego Resting State EEG Data from Patients with Parkinson's Disease, gathered from OpenNeuro.org the 21st of November of 2022